Actinium Pharmaceuticals, Inc. (ATNM) — research page
US · us-cm-kg/NYSE/ATNM · as of 2026-11-08
Identity and listing
The issuer is Actinium Pharmaceuticals, Inc., listed on the NYSE under ticker ATNM, with ISIN US00507W2061 and LEI 549300LCY1NZSXCQDT45. Its security type is Corporate and its sector is 2834 Pharmaceutical Preparations. Its jurisdiction is United States, Delaware. Its segment is not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Actinium Pharmaceuticals, Inc. | source · 2026-11-08 |
| exchange | NYSE | source · 2026-11-08 |
| ticker | ATNM | source · 2026-11-08 |
| ISIN | US00507W2061 | source · 2026-11-08 |
| LEI | 549300LCY1NZSXCQDT45 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 24 filings in the twelve months to 2026-11-08, on 15 filing days. The median gap between filing days is 20.5 days. The latest filing is dated 2026-10-16 and is of type directors_dealings, 23 days before the record date. The NYSE median cadence gap is 6.0 days and its median latency is 4.0 days, across 3256 issuers. The 2834 Pharmaceutical Preparations sector median cadence gap is 6.0 days and its median latency is 4.0 days, across 526 issuers.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 24 | 20.5 | 23 |
| exchange median: NYSE (3256 issuers) | 64 | 6 | 4 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-16 | directors_dealings | 4 | 4 |
| 2026-10-16 | directors_dealings | 3 | 3 |
| 2026-10-15 | regulatory_filing | ARS | ARS — ARS |
| 2026-10-15 | agm_egm | DEF 14A | DEF 14A — PROXY STATEMENT |
| 2026-10-15 | director_change | 8-K | 8-K — CURRENT REPORT (items 5.02,7.01,9.01) |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is CBIZ CPAS P.C, located in Houston, Texas. The record holds no auditor changes.
Events and halts
The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.
Orderability
The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
The issuer's own investor-relations page names five research houses: B. Riley, H.C. Wainwright, JonesTrading, Maxim Group and Stephens, Inc.
| research house | analyst | source · read date |
|---|---|---|
| B. Riley | Yuan Zhi, Ph.D. | issuer page · 2026-11-11 |
| H.C. Wainwright | Joseph Pantginis, Ph.D. | issuer page · 2026-11-11 |
| JonesTrading | Justin Walsh, Ph.D. | issuer page · 2026-11-11 |
| Maxim Group | Jason McCarthy, Ph.D. | issuer page · 2026-11-11 |
| Stephens, Inc. | Sudan Loganathan, Ph.D. | issuer page · 2026-11-11 |
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for the issuer. The market's vintage is sealed, with earliest sealed date 2021-01-04. The live record began on 2026-09-12.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001388320.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NYSE/ATNM (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/1388320/000121390026036504/ea0279291-10k_actinium.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://ir.actiniumpharma.com/analyst-coverage (coverage)
- 10.10
- https://mcp.us-cm-kg.ai/record/NYSE/ATNM (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US00507W2061"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:431076e47fcbbf5d.